This fact could explain the direct relationship between PCSK9 and atherosclerosis and why PCSK9 overexpression is proatherogenic, whereas its absence is protective, adding cardiovascular benefits for anti-PCSK9 therapies. This evidence concerns the gene PCSK9 and atherosclerosis.